Skip to content
healthcare.dev

Rifabutin

NDC 10135-738, Rifabutin, capsule, from Marlex Pharmaceuticals, Inc..

Product NDC
10135-738
Status
Listed
Labeler
Marlex Pharmaceuticals, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215041
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10135-738 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RIFABUTIN150 mg/1

Pharmacologic classes

Rifamycin Antimycobacterial [EPC]; Rifamycins [CS]

Package NDCNDC-11Package
10135-738-0110135073801100 CAPSULE in 1 BOTTLE (10135-738-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/df7d4103-42e4-4e4f-e053-2a95a90a8ce8

Use it

Look up 10135-738 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10135-738 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10135-738. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.